. Dilated nail-fold capillaries (age 12) The CREST syndrome is much more common in females. This form of systemic sclerosis tends to pursue a slowly progressive course. Severe renal or myocardial involvement is rare. However, there is a risk of serious complications even 30 years after the development of Raynaud's phenomenon (Rodnan et al. 1975 ). Severe pulmonary hypertension may develop, leading to progressive cor pulmonale and death. Pulmonary fibrosis may be minimal or absent.
Numerous antinuclear antibodies have been described in systemic sclerosis. The incidence depends on the substrate used. Routine testing for antinuclear factor on an organ substrate may be 'negative', but use of a more sensitive tissue culture cell substrate will increase the likelihood of detecting cellular antibodies. Recent studies have shown that the CREST syndrome can be separated serologically from other forms of scleroderma by its frequent association with anticentromere antibodies. The antibody was found in 26 of 27 patients with CREST syndrome, 3 of 14 patients with Raynaud's phenomenon, 3 of 26 patients with systemic sclerosis and 1 of 60 patients with systemic lupus erythematosus (Fritzler & Kinsella 1980 , Tuffanelli et al. 1983 . The presence of this antibody seems to justify the clinical separation of the CREST syndrome from other forms of systemic sclerosis. Male patients with progressive systemic sclerosis generally have a poor prognosis, but we believe that this man has a form of progressive systemic sclerosis which is slowly progressive with a prolonged delay in appearance of visceral changes. The significance of the anticentromere antibody is unknown. It may merely be an epiphenomenon, but perhaps it is more closely related to disease pathogenesis, implying disease activity. We report a patient who developed penicillamine dermopathy following high-dose D-penicillamine therapy for cystinuria, and in whom pseudoxanthoma elasticum-like skin changes subsequently developed; this does not appear to have been reported previously.
--
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Case report
The patient, a 59-year-old man, was diagnosed as having cystinuria at the age of 37 years; the diagnosis was based upon the history of many episodes of renal colic, the presence of multiple renal calculi on X-ray, the spontaneous passage At the age of 40 years he commenced oral Dpenicillamine therapy, initially receiving 2.4 g/day for eight years and subsequently 3 g/day until aged 59 years. During treatment with Dpenicillamine his urinary cystine excretion fell to 147 mg/24 hours. On several occasions whilst he was taking D-penicillamine, measurements of his serum and urinary copper were performed and consistently his serum copper was found to be below normal (2.5-8 g/l; normal range 12-25 g/l) and his urinary copper excretion considerably elevated (788-808 g/24 hours; normal range < 30 g/24 hours). At the age of 51 he developed haemorrhagic blisters with milia on his elbows (Figure 1 ), knees and shoulders. Histology of a representative lesion showed an intradermal bulla but no inflammatory cell infiltrate; the elastic fibres were increased in number in the upper half of the dermis, with coarse clumping and fragmentation of fibres. His treatment was unchanged and the blisters healed spontaneously, leaving slight scarring and milia.
At age 59 he was incidentally noted to have abnormal skin. Despite no history of excessive sun exposure in the past, the skin of his face was grossly elastotic. Over the neck and axillae ( Figure 2 ) the skin resembled 'plucked chicken skin' with elastotic papules and excessive wrinkling. Despite no change in his weight, the skin over his back and chest ( Figure 3 ) hung in loose, redundant folds. His peripheral pulses were of normal character and his blood pressure and optic fundi were normal. There was no family history of abnormal skin or of pseudoxanthoma elasticum. Histology of the axillary skin showed considerably increased elastin in the dermis; individual fibres had irregular protrusions, and there were many fragmented elastin fibres which in places had evoked a granulomatous reaction. There was no calcification of elastin fibres.
Electron microscopy of the axillary skin showed elastin fibres which were fragmented and' altered in shape, having multiple bulbous protrusions of an outer electron-lucent coat (Figure 4 ).
Collagen and elastin cross-links were estimated chemically in the skin of the patient (Light & Bailey 1982) ; the relative proportions of the two major genetic forms of collagen (types I and III) and an assessment of its maturity, were made by a peptide mapping technique (Light 1982) . The results showed that compared with skin from an age/sex-matched control from the same body site, the elastin content of the patient's skin was five times greater, and the quantity of cross-link precursors was two times greater; the elastin cross-link density, however, was only 10% of normal. The collagen content and ratio of type I to type III collagen were normal, but the protein appeared biochemically more like that of a young child. The increase in skin surface area (as judged by the large, loose, redundant folds of skin) suggested an excessive production of collagen, but its turnover rate appeared normal as judged by normal urinary hydroxyproline levels. Detailed biochemical analysis of the collagen metabolism in the skin of this patient will be published elsewhere (Light et al., in preparation) . Discussion D-Penicillamine is of proven value in the treatment of rheumatoid arthritis and in high doses is used to treat cystinuria (by reducing urinary cystine excretion) and Wilson's disease (by chelating copper).
Cystine is a disulphide amino acid which is excreted in abnormally high quantities in the urine i-r cystinuria; being insoluble it provokes the development of urinary calculi. D-Penicillamine therapy in cystinuria results in the development of the more soluble compound penicillamine-cysteine disulphide in the urine, thereby reducing urinary cystine excretion (Crawhall et al. 1963) .
Whilst the cutaneous manifestations of Dpenicillamine therapy are numerous (Sternlieb et al. 1981) , patients receiving very high doses of D-penicillamine (1.5-4g/day) over several years for treatment of Wilson's disease or cystinuria, are liable to develop cutaneous lesions which result from interference with collagen and elastin maturation by D-penicillamine.
Penicillamine dermopathy, as characterized by the symmetrical development of haemorrhagic Fjl;.. Journal of the Royal Society of Medicine Volume 77 September 1984 797 blisters over bony prominences (knees, elbows, knuckles, dorsa of feet and shoulders) which heal to leave milia, has accompanied the prolonged treatment with penicillamine of patients with Wilson's disease (Katz 1967 , Hashimoto et al. 1981 and cystinuria (Beer & Cooke 1967) . In a personal series of 40 cystinuric patients treated by one of us (ADS) for long periods with large doses of D-penicillamine, 7 patients developed this cutaneous complication.
Elastosis perforans serpiginosa, appearing as groups, lines or rings of erythematous or brownish warty papules in the axillae and antecubital fossae, and on the neck, has also been reported in patients treated for several years with large doses of penicillamine for Wilson's disease (Guilaine et al. 1972 , Pass et al. 1973 , Kirsch & Hukill 1977 , Bardach et al. 1979 ) and cystinuria (Hashimoto et al. 1981) .
Cutis hyperelastica and excessive skin 'ageing' and wrinkling over the face, neck and knees have been described in patients with Wilson's disease treated with D-penicillamine in large doses (Charlebois et al. 1972 , Greer et al. 1976 ); as far as we can discover, this is the first report of large doses of D-penicillamine causing the very striking cutaneous changes observed in our patient, which resemble those seen in pseudoxanthoma elasticum (the skin both hanging in loose redundant folds, and, due to the elastotic change, appearing like 'plucked chicken skin').
In both penicillamine dermopathy and Dpenicillamine induced elastosis perforans serpiginosa, electron microscopy of the skin has demonstrated distinct morphological changes of the elastin fibres. The individual elastin fibres have an amorphous electron-lucent coat from which arise swellings and bulbous protuberances at right angles to the microfibrils running in the long axis of the fibres. Such fibres have been described as 'lumpy-bumpy' elastin fibres (Bardach et al. 1979) . Identical electron-microscopic morphological abnormalities of elastin fibres were demonstrated in the pseudoxanthoma elasticum-like skin taken from the axilla of our patient (Figure 4) .
The levels of elastin cross-link precursors in the skin of our patient were found to be increased, but the elevated amount of elastin in the skin contains only a tenth of the normal cross-link number. This ineffective cross-linking probably accounts for the abnormal microscopic and electron-microscopic appearances of the elastin fibres. In addition, the cross-linking abnormality in combination with the excess elastin content of our patient's skin (as demonstrated by chemical quantitation) probably accounts for the abnormal clinical appearance of his skin.
The mechanism whereby D-penicillamine causes abnormalities of elastin in the skin has aroused speculation. It has been suggested that copper deficiency induced by D-penicillamine may be the underlying mechanism (Pass et al. 1973 , Hashimoto et al. 1981 ). D-Penicillamine chelates copper and thereby increases copper excretion; furthermore, D-penicillamine is preferentially concentrated in the skin (Ruocco et al. 1983 ) and it could therefore be that there is enhanced copper deficiency locally within the skin. Experimentally-induced copper deficiency produces a decrease in the amount of mature cross-linked elastin (Starcher et al. 1964 , Smith et al. 1968 ), probably as a consequence of inhibition of the enzyme lysyl oxidase (Lapiere 1973 ). Miller et al. (1965 demonstrated that copper deficiency in pigs led to a decreased production from lysine of desmosine and isodesmosine, the elastin cross-links; furthermore they demonstrated decreased incorporation of`4Clabelled lysine, thereby preventing formation or condensation of the intermediate compounds which normally form elastin cross-links.
One new aspect of the role of D-penicillamine arising from our studies is that we have shown that the drug may inhibit the natural maturation process of collagen in adults. Although normal preliminary cross-linking of the collagen was not demonstrably affected by the drug, the formation of more complex cross-links (and hence polymeric, highly stabilized collagen matrices) was inhibited. This could be due either to the drug stimulating cellular activity in degrading newly formed collagen or to its binding to preliminary collagen cross-links and thereby preventing their maturation. Such effects would not necessarily be expected to lead to increased production however, and it may be that the drug also activates collagen and elastin-producing cells, thereby accounting for the observed increase in these proteins in our patient's skin.
Whilst the mechanism whereby high-dose Dpenicillamine causes the production of abnormal cutaneous elastin fibres remains speculative, our results from studying the quantity and composition of the cutaneous elastin and collagen in our patient have clarified further the effects of high doses of the drug on the production of elastin and collagen in the skin, and thereby help to explain the development of penicillamineinduced cutaneous side effects due to interference with elastin and collagen production.
